Your browser doesn't support javascript.
loading
Ferulic acid prevents Diosbulbin B-induced liver injury by inhibiting covalent modifications on proteins.
Chen, Huiling; Liu, Chenchen; Li, Meng; Zhang, Yida; Wang, Zhendong; Jiang, Qiyao; Wang, Jianxin; Wang, Qi; Zhuo, Yue.
Afiliação
  • Chen H; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
  • Liu C; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
  • Li M; Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangdong Provincial Key Laboratory of Research in Structural Birth Defect Disease, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510405, China.
  • Zhang Y; Department of Allergy and Clinical Immunology, National Center for Respiratory Medicine, National Clinical Research Center for Respiratory Disease, State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, G
  • Wang Z; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
  • Jiang Q; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China.
  • Wang J; Department of Pharmaceutics, School of Pharmacy, Ministry of Education, Fudan University & Key Laboratory of Smart Drug Delivery, Shanghai, 201203, China.
  • Wang Q; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: wangqi@gzucm.edu.cn.
  • Zhuo Y; Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China. Electronic address: zhuoyue@gzucm.edu.cn.
Drug Metab Pharmacokinet ; 50: 100507, 2023 Jun.
Article em En | MEDLINE | ID: mdl-37075616

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Doença Hepática Induzida por Substâncias e Drogas / Doença Hepática Crônica Induzida por Substâncias e Drogas Idioma: En Revista: Drug Metab Pharmacokinet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Efeitos Colaterais e Reações Adversas Relacionados a Medicamentos / Doença Hepática Induzida por Substâncias e Drogas / Doença Hepática Crônica Induzida por Substâncias e Drogas Idioma: En Revista: Drug Metab Pharmacokinet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China